Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
| Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
|---|---|---|---|---|---|---|---|
| CANTOR FITZGERALD & CO. | 134 | CF ON3 Lifesciences Parent DST | 1928276 | 02/28/2023 | D/A | $69,800,000 | $69,800,000 |
| CANTOR FITZGERALD & CO. | 134 | CF Glenmuir Multifamily DST | 1872937 | 09/27/2021 | D | $86,100,000 | $67,664,789 |
| CANTOR FITZGERALD & CO. | 134 | CF Texas Multifamily Portfolio DST | 1885921 | 11/01/2021 | D/A | $94,811,000 | $66,449,557 |
| CANTOR FITZGERALD & CO. | 134 | X4 Pharmaceuticals, Inc | 1501697 | 06/01/2023 | D | $65,023,725 | $65,015,462 |
| CANTOR FITZGERALD & CO. | 134 | CF Livonia DST | 1778537 | 01/13/2020 | D/A | $61,900,000 | $61,900,000 |
| CANTOR FITZGERALD & CO. | 134 | CF ARRABELLA MULTIFAMILY DST | 1935650 | 02/07/2023 | D/A | $58,492,000 | $58,492,000 |
| CANTOR FITZGERALD & CO. | 134 | CF Chisholm Multifamily DST | 1899445 | 11/14/2022 | D/A | $55,500,000 | $55,500,000 |
| CANTOR FITZGERALD & CO. | 134 | Lyra Therapeutics, Inc. | 1327273 | 06/09/2023 | D | $50,000,008 | $50,000,008 |
| CANTOR FITZGERALD & CO. | 134 | CF Weston Multifamily DST | 1920796 | 03/03/2023 | D/A | $47,170,000 | $47,170,000 |
| CANTOR FITZGERALD & CO. | 134 | CF West End Multifamily DST | 1944748 | 02/07/2023 | D/A | $47,000,000 | $47,000,000 |